DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ:067080)

South Korea flag South Korea · Delayed Price · Currency is KRW
14,800
-50 (-0.34%)
At close: Aug 14, 2025, 3:30 PM KST
-0.34%
Market Cap259.25B
Revenue (ttm)148.54B
Net Income (ttm)652.26M
Shares Out17.52M
EPS (ttm)37.49
PE Ratio397.46
Forward PEn/a
Dividend150.00 (1.01%)
Ex-Dividend DateJun 27, 2025
Volume35,588
Average Volume254,658
Open14,850
Previous Close14,850
Day's Range14,730 - 14,960
52-Week Range9,340 - 24,150
Beta-0.15
RSI44.13
Earnings DateNov 11, 2025

About DAE HWA Pharmaceutical

DAE HWA Pharmaceutical Co., Ltd., a pharmaceutical company, produces and supplies pharmaceutical products in South Korea. The company offers drugs for anticancer, antibiotics, antifungal and skin ailment, antivirus, anti-allergosis, hemorrhoids, antidepressant, antiepileptic, psychotropic agent, anti respiratory, anti-inflammatory, analgesic, skeletal muscle relaxants, osteoporosis, anti-arthritis, gastro-intestinal, obesity, antispasmodic, diabetics, hypertension, hyperlipemia, antithrombotic and anticoagulant, hepatic, erectile dysfunction, u... [Read more]

Industry Pharmaceutical Preparations
Founded 1984
Employees 308
Stock Exchange KOSDAQ
Ticker Symbol 067080
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.